Stockscreener 앱 받기
123.01
0.84%
1.14
Illumina Inc 주식(ILMN)의 최신 뉴스
How Illumina multiomics helps scientists track elusive ovarian cancers - Stock Titan
Illumina Genome Push Raises Questions On Growth, Adoption And Valuation - simplywall.st
Illumina launches TruPath Genome, setting a new standard in genomic insight - Investing News Network
Illumina Launches TruPath Genome Workflow Solution - marketscreener.com
Illumina's TruPath Genome offers rapid whole genome testing for rare disease - Stock Titan
NovaSeq X Series innovation roadmap - Illumina
Next Generation Sequencing Market Competitive Landscape - GlobeNewswire
Illumina unveils NovaSeq X upgrades with 40% output increase - Investing.com Australia
Illumina, Inc. (ILMN) Stock Analysis: Exploring a 15.62% Potential Upside in the Genomics Sector - DirectorsTalk Interviews
Illumina, Inc. Unveils Roadmap of Groundbreaking NovaSeq X Advancements in Data Quality, Output, Speed, and Flexibility - marketscreener.com
Illumina Beat Q4 Earnings and Closed a $350M Acquisition. Here’s What Investors Need to Know - TIKR.com
Why Illumina Inc. stock is a must watch in 20252025 Support & Resistance & Free Verified High Yield Trade Plans - mfd.ru
This once-hot cancer-detection company’s stock got cut in half after a failed trial - MarketWatch
Illumina SVP Leckman sells $275k in stock By Investing.com - Investing.com South Africa
Illumina SVP Leckman sells $275k in stock - Investing.com Australia
Is It Time To Reassess Illumina (ILMN) After Recent Share Price Volatility - Yahoo Finance
We Think That There Are Some Issues For Illumina (NASDAQ:ILMN) Beyond Its Promising Earnings - 富途牛牛
Insider Sell: Patricia Leckman Sells Shares of Illumina Inc (ILM - GuruFocus
Illumina Stock is Down 80% From Its All-Time Highs: Can It Recover in 2026? - TIKR.com
DNA Sequencing Market Is Booming So Rapidly by 2033 | Thermo Fisher Scientific, Inc., Illumina - openPR.com
Illumina Single Cell RNA Seq helps advance avian conservation - Illumina
Buyout Rumor: What is the Moat Score of Illumina IncMarket Performance Summary & Weekly Top Stock Performers List - baoquankhu1.vn
Illumina To Webcast Upcoming Investor Conference - marketscreener.com
Illumina, Inc. (ILMN) Stock Analysis: Evaluating a 16% Upside Potential Amidst Strong Growth Metrics - DirectorsTalk Interviews
Decoding early synaptic failure in Alzheimer’s disease through multiomic analysis - Illumina
Illumina’s AI-Driven Data Vision Is Expanding — Will Multiomics Integration Unlock a Transformational Edge? - Smartkarma
The future of global food security may depend on quality agrigenomics software - Illumina
Illumina Conservation Deal Highlights New Genomics Demand And Valuation Debate - Sahm
How Illumina Inc. stock performs during Fed tightening cyclesDip Buying & Stepwise Entry and Exit Trade Signals - mfd.ru
Illumina (NASDAQ:ILMN) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
From sample to insight: Streamlining analysis with the Illumina 5-base solution - Illumina
Illumina completes acquisition of SomaLogic from Standard BioTools - BizWest
Decoding Our DNA: The Human Impact Behind SNP Genotyping’s USD 19.48 Billion Growth by 2034 - GlobeNewswire Inc.
Illumina, Inc. $ILMN Stock Holdings Lowered by Rhumbline Advisers - MarketBeat
Krilogy Financial LLC Takes $1.34 Million Position in Illumina, Inc. $ILMN - MarketBeat
Illumina Crash 10% on Earnings: Why the Stock Could Rebound to $185 in 2026 - TIKR.com
Decoding Illumina Inc (ILMN): A Strategic SWOT Insight - GuruFocus
How Illumina Inc. stock trades before earningsGap Down & Weekly High Return Stock Opportunities - mfd.ru
Illumina (ILMN) is a Top-Ranked Growth Stock: Should You Buy? - Nasdaq
Illumina Q4 Earnings & Revenues Top Estimates, Stock Dips - Nasdaq
Illumina's (NASDAQ:ILMN) Profits Appear To Have Quality Issues - Yahoo Finance
5 Insightful Analyst Questions From Illumina's Q4 Earnings Call - Finviz
5 Insightful Analyst Questions From Illumina’s Q4 Earnings Call - Yahoo Finance
Insider Buying: Scott Gottlieb Acquires Shares of Illumina Inc (ILMN) - GuruFocus
Scott Gottlieb Buys 200 Shares of Illumina (NASDAQ:ILMN) Stock - MarketBeat
Ngs Oncology Market Is Going to Boom | Illumina • Roche • Thermo Fisher Scientific - openPR.com
Simplifying library prep: All in a day’s work for Louise Fraser - Illumina
Can Illumina Inc. (ILU) stock expand revenue streams2025 Bull vs Bear & Comprehensive Market Scan Insights - mfd.ru
Illumina Looks To Clinical Consumables And China Restart To Offset Intensifying NGS Price Pressure - Citeline News & Insights
Spatial Genomics and Transcriptomics Market size to cross - openPR.com
Illumina, Inc. $ILMN Shares Sold by GUARDCAP ASSET MANAGEMENT Ltd - MarketBeat
Introduction to the MiSeq™ i100 Series Tech Support Webinar - Illumina
Multiomics Market Forecast Through 2033: Size, Share, Trends, - openPR.com
My path to Illumina - Illumina
Unlocking Illumina (ILMN) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance
This Week in Chancery Court: Trump Media SPAC Appeal, Illumina - Bloomberg Law News
Illumina, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - 富途牛牛
0.83%
1.15%
자본화:
|
볼륨(24시간):